Industry & Policy News

[Fixstars Solutions] The Weissman Lab, led by Dr. Irving Weissman, a professor at Stanford University in Pathology and Developmental Biology, will be working directly with Fixstars Solutions starting in July, 2023. Fixstars and Dr. Weissman will collaborate on in-situ sequencing research.

[ImmunoGenesis (PRNewswire)] ImmunoGenesis announced that Cancer Focus Fund plans to invest $4.5 million to support the Phase Ia/Ib clinical trial of ImmunoGenesis' lead candidate, IMGS-001.

[Monash University] Professor Harshal Nandurkar was awarded the member of the General Dicision as part of this year's King's Birthday Honours. He was recognized for his significant service to medicine, particularly as a hematologist.

[East Tennessee State University] East Tennessee State University’s Dr. Aaron Polichnowski was recently awarded a $601,092 grant from the National Institutes of Health to research a possible link between blood vessel function and hypertension – particularly salt-sensitive hypertension.

[AGEPHA Pharma] AGEPHA Pharma USA, LLC announced that, following a Priority Review, the US FDA has approved LODOCO® as the first anti-inflammatory atheroprotective cardiovascular treatment.

[Fierce Biotech] Zenyaku Kogyo is lining up a challenge to Sanofi and Regeneron’s blockbuster Dupixent in Japan, paying Aslan Pharmaceuticals $12 million upfront for local rights to a midphase eczema drug candidate.